DNA Link Inc (127120) — Cash Flow Reinvestment Rate
DNA Link Inc (127120) has a Cash Flow Reinvestment Rate of 1.64x as of December 2023, reinvesting ₩2.48 Billion (capex ₩786.91 Million plus investments ₩-1.69 Billion) from operating cash flow of ₩1.51 Billion. Check 127120 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DNA Link Inc Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for DNA Link Inc across 2 annual periods. Explore 127120 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for DNA Link Inc (2020–2022)
Year-by-year capital reinvestment analysis for DNA Link Inc. For live market cap and broader valuation context, see 127120 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 8.36x | ₩7.61 Billion | ₩910.27 Million | ₩4.93 Billion | ▲ +104.1% |
| 2020 | 4.09x | ₩3.48 Billion | ₩849.38 Million | ₩1.10 Billion | — |